S.A. Berry, C. Brown, M. Grant, C.L. Greene, E. Jurecki Newborn screening 50 years later: access issues faced by adults with PKU Genet.http://scholar.google.com
 
 
 
 
 
Risk factor
Harris, Benjamin S. MD, MPH; Bishop, Katherine C. MD; Kemeny, Hanna R. BS; Walker, Jennifer S. MLS; Rhee, Eleanor MD; Kuller, Jeffrey A. MDRisk -Factors for Birth Defects: February 2017 - Volume 72 - Issue 2 - p 123-135[PubMed] [Google Scholar] 
.(11)Chace DH, Millington DS, Terada N, Kahler SG, Roe CR, Hofman LF. Rapid diagnosis of phenylketonuria by quantitative analysis for phenylalanine and tyrosine in neonatal blood spots by tandem mass spectrometry..(5) Robin Wallims, Phenylketonuria: An Inborn Error of Phenylalanine Metabolism,2008 from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2423317  
Naz Al Hafid Phenylketonuria: a review of current and future treatments,2015 from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728993     (6)./ 
Symptoms
Blau N. Genetics of Phenylketonuria: Then and Now.Ashraf El metwaly, The Prevalence of Phenylketonuria in Arab Countries, Turkey, and Iran: A Systematic Review,2018 from  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932526(4).1993;39:66-71 [PubMed] [Google Scholar] 
 
.(12) Blau N, Hennermann JB, Langenbeck U, Lichter-Konecki U. Diagnosis, classification, and genetics of phenylketonuria and tetrahydrobiopterin (BH4) deficiencies.[PMC free article] [PubMed] [Google Scholar]
 
.(14) Park J, Jang W, Chae H, Kim Y, Chi HY, Kim M, et al. Comparison of targeted next-generation and sanger sequencing for the BRCA1 and BRCA2 mutation screening.[PubMed] [Google Scholar] 
 
 
.(13) Park J, Jang W, Chae H, Kim Y, Chi HY, Kim M, et al. Comparison of targeted next-generation and sanger sequencing for the BRCA1 and BRCA2 mutation screening.(intoduction)
 
incednt 
 William L. Stone; phenylketonuria,2019, pubmed from  https://www.ncbi.nlm.nih.gov/books/NBK535378(3).[PubMed] [Google Scholar] 
.(10) Yang L, Mao H, Yang R. Delays in referral, and parents refusing treatment for children with PKU.(8) Blau NT, Cotton RG, Hyland K. Disorders of tetrahydrobiopterin and related biogenic amines.[Google Scholar]
.(9) Blau N, van Spronsen FJ, Levy HL. Phenylketonuria.(introduction)
 
 
Palermo, L., Geberhiwot, T., MacDonald, A., Limback, E., Hall, S. K., & Romani, C. (2017).Cognitive outcomes in early-treated adults with phenylketonuria (PKU): A comprehensive picture across domains.Management of phenylketonuria: a consensus document for the diagnosis and management of children, adolescents and adults with phenylketonuria (PKU).The Metabolic and Molecular Bases of Inherited Disease.[PMC free article] [PubMed] [Google Scholar] 
Treatment?????"Recombinant  Phe-free proteins for use in the treatment of phenylketonuria."http://www.nspku.org/.Journal of Inborn Errors of Metabolism and Screening, 5, 2326409816685734(17).Mol Genet Metab.Li, Qingshan, and Olof Kampe.National Society for Phenylketonuria (UK) Ltd.Hum Mutat.doi: 10.1002/humu.22980.Epub 2016 Mar 18.Citation on PubMed(7).In: Scriver CR, editor.Clin Chem.NSPKU (National Society for Phenylketonuria).Alternative therapies for PKU.Med., 15 (2013), pp. 591-599(1).Neuropsychology, 31(3), 255-267(2).2016 Jun;37(6):508-15.diagnosis
 
.New York: McGraw Hill; 2001.pp. 1725-76.Lancet.2011;104(Suppl):S2-9.Ann Lab Med.Ann Lab Med.U.S. Patent No. 10,174,354.Accessed 1 June 2016\ (16).Specola, N., & Chiesa, A. (2017).Review.2010;376:1417-27.2011;18:214.2016;36:197-201.(2014).